Literature DB >> 2903142

The role of neuroleptics in manic-depressive illness.

J M Kane1.   

Abstract

Neuroleptic drugs are a common treatment for acute mania. Although lithium alone may be effective, for those patients with moderate or severe agitation neuroleptics appear to be superior. Low-potency and high-potency neuroleptics are equally effective in mania, as in schizophrenia. Patients with affective disorders, however, may be highly susceptible to the pseudoparkinsonian or extrapyramidal side effects that can occur with neuroleptics. Moderate doses of neuroleptics can be effective in most patients and can reduce the likelihood of serious side effects. Many bipolar patients have manic relapses despite adequate serum lithium levels, and many of those patients are subsequently maintained on a regimen of neuroleptic drugs in addition to lithium. Using the lowest possible dose of the neuroleptic may decrease the high, long-term risk of tardive dyskinesia. More clinical research is needed to determine the most appropriate use of neuroleptic drugs in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903142

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

Review 1.  A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.

Authors:  R M Post; S R Weiss
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

2.  Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex.

Authors:  E Acquas; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 3.  Pharmacological treatment of bipolar disorder among children and adolescents.

Authors:  Joseph C Blader; Vivian Kafantaris
Journal:  Expert Rev Neurother       Date:  2007-03       Impact factor: 4.618

4.  Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.

Authors:  Shahin Akhondzadeh; Hassan Mohajari; Mohammad Reza Mohammadi; Homayoun Amini
Journal:  BMC Psychiatry       Date:  2003-06-19       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.